Fondo Bibliografico Internacional Mayo 2004
8.- Hepatitis tóxicas y fulminantes.
Elevated Resistive Index in the Hepatic Artery as a Predictor
of Fulminant Hepatic Failure in Patients with Acute Viral Hepatitis: A Prospective
Study Using Doppler Ultrasound. Katsuaki Tanaka, Kazushi Numata, Manabu Morimoto,
et al. Digestive Diseases and Science 2004;49:839-842.
Índices de resistencia de la arteria hepática elevados
como factor preditor de insuficiencia hepática fulminante en pacientes
con hepatitis aguda.
Tamoxifen induced hepatotoxicity in breast cancer patients
with pre-existing liver steatosis: the role of glucose intolerance. Elefsiniotis
IS, Pantazis KD, Ilias A, et al. European Journal of Gastroenterology and
Hepatology 2004;16:593-8.
Hepatotoxicidad inducida por tamoxifeno en pacientes con esteatosis
hepática.
Patients with elevated liver enzymes are not at higher risk
for statin hepatotoxicity. Naga Chalasani, Hisham Aljadhey, Joe Kesterson,
et al. Gastroenterology 2004;126:1287-1292.
La hipertransaminasemia en pacientes dislipémicos no aumenta
el riesgo de hepatotoxicidad por estatinas.
Are patients with elevated liver tests at increased risk of
drug-induced liver injury?. Mark W. Russo, Paul B. Watkins. Gastroenterology
2004;126:1477.
Editorial.
Hepatic adducts, circulating antibodies, and cytokine polymorphisms
in patients with diclofenac hepatotoxicity. Guruprasad P. Aithal, Lesley Ramsay,
Ann K. Daly, et al. Hepatology 2004;39:1430-1440.
Polimorfismos genéticos y hepatotoxicidad por diclofenaco.
